COR · Cencora, Inc.
$324.802026-05-17Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$383
+17.9% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($303 · $424) Analysts Range ($340 · $440) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2022.Q1 | $214.0B | — | 1.3% | 29.5% | $1.9B | −$5.2B | −$3.3B | 4.8% | — | 50.3% | $3.8B | $7.88 | — |
| 2023.Q1 | $238.6B | 11.5% | 1.2% | 22.3% | $2.1B | −$1.4B | $753MM | 6.9% | — | 58.0% | $3.6B | $8.70 | — |
| 2024.Q1 | $262.2B | 9.9% | 0.9% | 20.9% | $1.9B | $2.8B | $4.7B | 6.9% | — | 61.1% | $2.7B | $8.94 | — |
| 2025.Q1 | $294.0B | 12.1% | 1.0% | 23.4% | $2.3B | −$4.5B | −$2.2B | 7.8% | — | 60.0% | $5.0B | $7.73 | — |
| 2026.Q1 | $325.8B | 10.8% | 1.2% | 30.1% | $2.7B | $227MM | $2.9B | 7.3% | — | 41.4% | $8.0B | $8.32 | 16.4 |
| italics below = DCF projection · 10yr Rev CAGR: 7.8% |
| 2027.Q1 | $352.1B | +8.1% | 1.1% | 29.1% | $2.8B | −$1.6B | $1.3B | 7.4% | $1.2B | 32.2% | $9.6B | $14.52 | 22.4 |
| 2028.Q1 | $376.1B | +6.8% | 1.2% | 28.1% | $3.2B | −$974MM | $2.2B | 7.5% | $1.9B | 31.9% | $10.6B | $16.47 | 19.7 |
| 2029.Q1 | $405.6B | +7.8% | 1.2% | 27.1% | $3.7B | −$902MM | $2.8B | 7.7% | $2.2B | 33.3% | $11.5B | $18.77 | 17.3 |
| 2030.Q1 | $447.1B | +10.2% | 1.3% | 26.1% | $4.1B | −$1.2B | $3.0B | 7.8% | $2.2B | 34.3% | $12.6B | $21.16 | 15.3 |
| 2031.Q1 | $495.6B | +10.8% | 1.3% | 25.1% | $4.6B | −$1.3B | $3.4B | 7.9% | $2.3B | 35.0% | $13.9B | $23.77 | 13.7 |
|
| Term. Yr+ | $716.1B | 4.1% | 1.2% | 20.0% | $6.7B | −$1.2B | $5.5B | 8.6% | $57.3B | 23.6% | — | — | — |
Active scenario IV: $383 (+17.9% vs market)